ReutersShares of the Ltd. traded at Rs 952.5 on BSE at 10:57AM (IST) on Tuesday, up 1.29 per cent. The stock quoted a 52-week low price of Rs 737.9 and a high of Rs 1063.75.
Earlier in the day, the stock saw a gap up opening.
At the prevailing price, the stock traded at 10.44 times its trailing 12-month EPS of Rs 91.05 per share and 1.44 times its book value, as per BSE data.
A total of 26,088 shares changed hands on the counter till 10:57AM (IST). The stock commands a market value of Rs 55713.97 crore and is part of the Pharma - Indian industry.
The scrip has been an underperformer , up 17.71 per cent in the past one year in comparison with a 43.35 per cent gain in Sensex.
During the day, the stock moved between Rs 953.3 and Rs 938.25.
Promoter/FII Holding
Promoters held 48.86 per cent in the company as of 31-Mar-2021. FII and MF ownership in Aurobindo Pharma Ltd. stood at 24.37 per cent and 8.84 per cent, respectively.
Earlier in the day, the stock saw a gap up opening.
At the prevailing price, the stock traded at 10.44 times its trailing 12-month EPS of Rs 91.05 per share and 1.44 times its book value, as per BSE data.
Did you Know?
Stock score of Aurobindo Pharma Ltd moved down by 2 in 3 months on a 10-point scale.
View Latest Stock Report »A total of 26,088 shares changed hands on the counter till 10:57AM (IST). The stock commands a market value of Rs 55713.97 crore and is part of the Pharma - Indian industry.
The scrip has been an underperformer , up 17.71 per cent in the past one year in comparison with a 43.35 per cent gain in Sensex.
During the day, the stock moved between Rs 953.3 and Rs 938.25.
Promoter/FII Holding
Promoters held 48.86 per cent in the company as of 31-Mar-2021. FII and MF ownership in Aurobindo Pharma Ltd. stood at 24.37 per cent and 8.84 per cent, respectively.
Download The Economic Times News App to get Daily Market Updates & Live Business News.
